INTRODUCTION
The number of human HBV (hepatitis B virus) patients exceeds over 400 million people worldwide, causing acute and chronic B type hepatitis in these patients. It has been reported that chronic HBV infection is associated with the development of HCC (hepatocellular carcinoma) and liver diseases, and infection carries a 100-fold-higher risk of developing HCC [1] .
HBV has a partially double-stranded 3.2 kb DNA genome, containing 4 open reading frames which encode 4 proteins: Cp (core protein), Sp (surface protein), polymerase and X protein, HBx. The Cp plays an essential role in the life cycle of HBV, and packaged with the HBV genome, polymerase and host factors such as PKC (protein kinase C) and Hsp90, is Cp [2] . Therefore core assembly is a very important step in the life cycle of HBV.
Cp is 183 or 185 amino acids in length and consists of an Nterminal assembly domain (amino acids 1-149; Cp149), which is related to core assembly, and a C-terminal protamine domain (amino acids 150-183 or 185), which is known to play a role in the regulation of viral replication [2] . Cp149 is a 34-residue C-terminal truncated form which spontaneously forms a capsid under suitable conditions in vitro and in vivo [3] . This protein has been used for the research of capsid assembly because it can be overexpressed in Escherichia coli more efficiently than fulllength Cp and is structurally similar to the HBV core [4] , as well as being easily purified. The C-terminal truncated form, Cp149, purified from E. coli was used in the present study.
Cp is a known phosphoprotein and several kinases, including 46 kDa serine kinase [5] , PKC (protein kinase C) [6] , SRPK1 (serine/arginine protein-specific kinase 1), and SRPK2 [7] , have been found to phosphorylate the C-terminal domain of Cp.
Phosphorylation of residues in the C-terminus of Cp has been implicated in the encapsidation of the pgRNA (pregenomic RNA)-polymerase complex, viral genome, replication and capsid localization. HBx increases HBV replication [8] ; however, previous reports also suggest that phosphorylation is one of the factors that affects capsid formation. For instance, PKA (protein kinase A)-mediated phosphorylation increases HBV capsid assembly [9] .
Capsid stability is a key issue in the life cycle of viruses, because capsid protects packaged viral and host factors. It is not known precisely which factors affect the HBV capsid stability. It is reported that a mutation at Ile 97 of Cp did not affect capsid stability [10] . Mutations affect virion stability by altering the capsid assembly and stability, as shown in cowpea chlorotic mottle virus [11] . Recently, PKA-mediated phosphorylation was suggested to affect HCV (hepatitis C virus) capsid stability [12] and the quaternary structure of the DHBV (duck HBV) capsid is stabilized by phosphorylation [13] .
PKC is known to be packaged in the HBV capsid and to play a role in the development of cancer [14] , and PKC is activated by HBx [15] . PKC also increased pgRNA encapsidation through phosphorylation of the C-terminus of Cp [16] , but neither the N-terminal residue phosphorylated by PKC nor the role of the C-terminal phosphorylation have been cleary defined.
In the present study, we observed that Ser 106 of Cp149 was phosphorylated by PKC and that the PKC-mediated phosphorylation increased a capsid levels and stability by increasing the Cp dimer affinity. The secondary structure of the PKC-phosphorylated capsid was more stable than that of the non-phosphorylated capsid. We observed that the levels of capsid and virus titre were decreased in Huh7 human hepatoma cells transfected with Cp
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mutant S106A. These results suggest that phosphorylation of Cp at Ser 106 increase capsid assembly and stability, which may affect the life cycle of HBV.
MATERIALS AND METHODS

Site-directed mutagenesis
Site-directed mutagenesis was performed with pET-28b-Cp149 as a template. The procedure followed standard site-directed mutagenesis protocols (Qiagen). Mutations (underlined) were confirmed by nucleotide sequencing. The following forward (F) and reverse (R) primers were used: S106A, F-5 -CTATTGTGGTTT-CACATTGCCTGTCTTACTTTTGGAAGAG-3 , R-5 -CTCT-TCCAAAAGTAAGACAGGCAATGTGAAACCACAATAG-3 ; S26A, F-5 -GCCTTCTGACTTCTTTCCTGCTGCTCGAGAT-CTCCTCGAC-3 , R-5 -GTCGAGGAGATCTCGAGCAGCAG-GAAAGAAGTCAGAAGGC-3 ; T70A, F-5 -GAGTTGATGAA-TCTGGCCGCCTGGGTGGGAAGTAATTTG-3 , R-5 -CCA-ATTACTTCCCACCCAGGCGGCCAGATTCATCAACTC-3 ; T114A, F-5 -CCTGTCTTACTTTTGGAAGAGAAGCTGTGC-TGGAGTATTTGGTG-3 , R-5 -CACCAAATACTCCAGCAT-AGCTTCTCTTCCAAAAGTAAGACAGG-3 .
Cp149 WT (wild-type) and mutant expression and purification
Cp149 and Cp149 mutants were cloned directly from pET28b vector (Novagen). Constructs were transformed into BL21(DE3) + pLysS E. coli (Novagen) and purified as described previously [17] . Purified dimers were stored in glycine buffer pH 9.5. In this pH, core dimers are stable [3] .
Determination of binding affinity of proteins using SPR (surface plasmon resonance)
SPR analysis was performed using a Biacore 3000 instrument (Biacore AB). Samples of Cp149 treated with or without PKC were denatured with 3.5 M urea and fractionated for the purification of Cp149 dimers as described previously [17] . FC1 (flow cell 1) contained a protein-free negative control, while experimental FC2 and FC3 contained Cp149(WT) and PKC-treated WT dimeric Cp149 respectively, which were immobilized according to the manufacturer's instructions. Affinity was measured as described previously [9] . Results were analysed using BIAevaluation software version 3.1 (Biacore AB).
Detection of PKC-mediated Cp149 phosphorylation and assembly
For the experiments, 20 μM of purified dimeric Cp149 was incubated with reaction buffer (10 mM Hepes, pH 7.5, 10 mM MgCl 2 and 1.67 mM CaCl 2 ), 10 μM ATP and 1 unit of PKC (Promega). Samples were incubated at 30
• C for 30 min. Samples were separated by electrophoresis on a 0.9 % native gel followed by immunoblot blot analysis with anti-HBc antibody (DAKO, Glostrup, Denmark) as described previously [17] . Band intensities were analysed using ImageMaster 2D Elite software 4.01 (Amersham Pharmacia Biotechnology). In these experiments, designed to detect phosphorylation of Cp149, 10 μM [γ -32 P]ATP (3000 Ci/mmol) was used instead of unlabelled ATP.
Detection of core capsid stability
Non-phosphorylated and phosphorylated capsid were incubated in urea at the indicated concentration (0-3 M). Samples were then separated by electrophoresis on a 0.9 % native gel, followed by Western blot analysis with anti-HBc antibody (DAKO, Glostrup, Denmark) as described previously [9] .
Sucrose gradient
After samples were incubated in assembly and dissociation conditions, sucrose gradient centrifugation (1 ml of 50 %, 1 ml of 40 %, 1 ml of 30 %, 1 ml of 20 % and 700 μl of 10% sucrose in 150 mM Hepes, pH 7.5) was performed by centrifuging for 90 min at 46 000 rev./min at 20
• C using a P55ST2 rotor (Hitachi koki). Fractions of 500 μl were collected and loaded on to a SDS/15 % PAGE gel, followed by immunoblot analysis with antiHBc antibody.
CD analysis
CD measurements were carried out with a J-810 (Jasco). Spectra were obtained using 2 nm bandwidth, a scan rate of 100 nm/min and a response time of 1 s. The quartz cuvette pathlength was 1 mm. The CD measurements were made using protein concentrations of 0.25 mg/ml Cp149. The solvent was 20 mM Tris/HCl, pH 7.2, and contained no salt. All CD measurements were performed at 20
• C.
Electron microscopy
In vitro Cp149 assembly was performed. A volume of 10 μl Cp149 particles in solution was applied to a carbon-coated grid and incubated for 1 min. The grid was washed with water and stained with 2 % uranyl acetate for 1 min. Transmisson electron micrographs were taken on a JEM 1010 (JEOL, Tokyo, Japan) operating at 80 kV at the NICEM (National Instrumentation Center for Environmental Management).
Detection of cytoplasmic capsid by agarose gel electrophoresis
Huh7 cells were maintained in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10 % fetal bovine serum (Gibco). Huh7 cells were transfected with pRcCMV/FLAGcore 149, pRcCMV/FLAG-S106A mutant core, pUC1.2x and pUC1.2x/S106A using FuGENE6 (Roche). After transfection, the cells were cultured for 2 days and harvested. Cytoplasmic capsids were detected as previously described [18] .
Detection of HBV DNA
Huh7 cells were transfected with pUC/HBV 1.2x and pUC/HBV 1.2x/S106A core using FuGENE6. The pUC/HBV 1.2x construct is similar to a previously described construct [18] that supports HBV replication and provides all the required HBV transcripts. Transfected cells were sonicated. The intracellular capsid particle was mixed with 0.5 ml of immunoprecipitation buffer contaning 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.2 % Nonidet P-40 and the anti-HBcAg rabbit polyclonal antibody (DAKO). Immunoprecipitated capsid particles were washed three times in 1 × PBS. Immunoprecipitated capsids were treated with DNase I for 1 h at 37 • C. Extracellular HBV DNA was extracted from the media and then measured by real-time quantitative PCR conducted with primers for the core region: F-5 -GGATCCGTCCAG-GGAATTGGTAGTC-3 , R-5 -TCAAAGAAAAGTAAGACA-GGAAAT-3 .
RESULTS
Phosphorylation of Cp149 by PKC increases capsid assembly
To investigate phosphorylation of Cp149 by PKC, we performed an in vitro kinase assay. The assembled Cp149 was phosphorylated by PKA and PKC ( Figure 1A , top panel), and capsid levels were increased by PKC and PKA phosphorylation ( Figure 1A , bottom panel). In the absence of PKC and PKA, assembled core particles were not phosphorylated, and there was no increase in capsid levels ( Figure 1A ). Sucrose gradient analysis was also used to confirm the PKC-mediated increase in core capsid ( Figure 1B ). To determine whether the Cp was specifically phosphorylated by PKC, an in vitro kinase assay was carried out using the PKC inhibitor calphostin C (Sigma). The phosphorylation of assembled Cp149 was inhibited and the level of assembled Cp was also reduced by calphostin C (Figures 1C and 1D ). Core phosphorylation was completely inhibited by 50 nM calphostin C. These results show that PKC specifically phosphorylates the HBV core and increased assembled core levels.
Analysis of core-core interactions using the SPR technique
HBV core affinity is increased by PKA [9] . To investigate the cause of enhanced in vitro core assembly following PKC phosphorylation, SPR was used to assess the binding affinity between Cp149 dimers. Sensorgrams of the interaction between dimeric Cp149 are shown in Figure 2 , and the values for kinetic parameters of association between the dimers are listed in Table 1 . The K a value of the interaction between PKC-phosphorylated WT (P-WT) and P-WT (Table 1 , row 3) was 14.19-fold higher than the K a value of the interaction between WT proteins alone. In addition, the K d value of the interaction between P-WT proteins was 6.21-fold lower than the K d value of the interaction between WT proteins. The equilibrium dissociation constant (K D ) is defined as K d /K a , which represents the affinity between the molecules. The K D of the interaction between P-WT core and WT ( rows 1 and 3) . These results suggest that the increased affinity between phosphorylated core dimers is primarily due to the elevated rate of dimeric core association and the reduced rate of dissociation (Figure 2 ).
HBV capsid stability is increased by PKC-mediated phosphorylation
On the basis of the observation that the K d value for the core-core interaction was decreased (Table 1) , we performed experiments to determine the effect of PKC-mediated phosphorylation on capsid stability using non-phosphorylated and phosphorylated capsid. The capsid stability experiment conducted previously with an HBV core mutant [10] utilized detergents, including urea, SDS and Gu-HCl, to create dissociation conditions [10] . However, only urea was used in our experiments, because SDS and Gu-HCl are known to change the electrophoretic mobility of proteins [10] . Urea was used as a dissociation factor in the core purification step. Capsid levels were decreased by increasing the concentration of urea ( Figure 3A) . When compared, levels of phosphorylated capsid levels remained 2.2 times higher than those of non-phosphorylated capsid in 3 M urea ( Figure 3A) . To assess capsid stability further, sucrose gradient experiments were performed ( Figure 3B ). These results showed that capsid stability was increased by PKC-mediated phosphorylation. To identify the PKC phosphorylation site of Cp149, Cp149 mutants (S26A, T70A, S106A and T114A) were constructed using site-directed mutagenesis. In vitro phosphorylation was performed with each purified mutant Cp149. We found that the Ser 106 mutant was not phosphorylated by PKC ( Figure 4A ). To confirm the PKC phosphorylation site of the core, in vitro assembly was assessed with WT and S106A mutant Cp149. WT assembled core levels were increased when WT Cp149 was incubated with PKC and ATP, but assembled Ser106A mutant core levels were not ( Figure 4B, lanes 4 and 8) . When the WT and the S106A mutant were incubated without PKC, the assembled core levels were not increased ( Figure 4B, lanes 1-3 and lanes 5-7) . Capsid Cp149(WT) was immobilized on FC2, and phosphorylated Cp149 was immobilized on FC3. Five concentrations of Cp149 and phosphorylated Cp149 dimers (0, 2.5, 5 and 10 μM) were passed though the flow cell at a flow rate of 60 μl/min. Sensorgrams were analysed using the BIAevaluation software version 3.1 and the results are shown in Table 1 .
Table 1 Binding parameters determined from kinetic analysis
Sensorgrams of the interaction between phosphorylated and non-phosphorylated dimeric Cp149 are shown in Figure 2 , and values for the corresponding kinetic parameters are listed here. stability was confirmed by sucrose gradient analysis ( Figure 4C ). Capsid stability was also confirmed. The levels of WT capsid did not increase when it was not incubated with PKC ( Figure 4D ). Additionally, there was no difference in capsid levels between S106A mutant capsid incubated with or without PKC ( Figure 4D ): incubation with PKC showed no effect on S106A mutant capsid stability. These data showed that Ser 106 is the site of PKC-mediated phosphorylation.
Time course assembly
To confirm further the site of PKC phosphorylation, the time courses of core assembly for WT Cp149, PKC-treated Cp149 and the PKC-treated S106A mutant Cp149 were assessed. WT Cp149 capsid levels assembled faster in the presence of PKC than those in the absence of PKC. The S106A mutant incubated with PKC showed no increase in assembled capsid levels when compared with non-phosphorylated Cp149 ( Figure 5A ). The intensity of the PKC-untreated Cp149 band after 15 min ( Figure 5A , top panel, lane 2) was used as a standard, and the relative intensities of other bands were analysed using ImageMaster 2D Elite software 4.01 ( Figure 5B ). Because all reactions contained the same amount of WT or S106A mutant, the capsid level in all the samples was (A) For in vitro kinase assays, PKC was incubated with purified Cp149 and S106A mutant Cp149 at 30 • C for 30 min in the presence of 32 P-labelled ATP. Samples were detected by using a BAS radio detector. (B) Cp149 and S106A mutant Cp149 were incubated with or without ATP and PKC. Native gel electrophoresis and immunoblot analysis were performed as described in the Materials and methods section. Band intensities were normalized to the intensity of lane 1, and this lane was set as the standard. (C) Cp149 and S106A mutant Cp149 were incubated with or without PKC at 30 • C for 30 min. After the reaction, sucrose gradient centrifugation was performed as described in the Materials and methods section. (D) Purified capsids were incubated in 3 M urea buffer at 37 • C for 1 h. Samples were separated on a 0.9 % native agarose gel and detected by immunoblot analysis. WT, WT Cp149; S106A mutant, S106A mutant Cp149. Band intensities were normalized to the intensity of lane 1 and this lane was set as the standard.
saturating after 90 min. These results show that the capsid levels of WT Cp149 were increased by PKC, whereas capsid levels of S106A Cp149 was not.
Secondary structure analysed by CD
To demonstrate that PKC enhances secondary structure stability as well as capsid stability, the overall conformations of both non-phosphorylated and phosphorylated capsid were measured by CD analysis. The HBV core exhibits a largely helical structure [19]. It was confirmed that capsid untreated by urea exhibited the spectra typical of α-helix-containing proteins, with a negative peak at 208 nm and 220 nm and a positive peak at 195 nm ( Figure 6, trace A) . The ratio of α-helix in PKC phosphorylated capsid was decreased ( Figure 6 , trace C), but not in the PKCtreated S106A mutant capsid ( Figure 6, trace B) . CD spectra showed the same loss of secondary structure in both WT and S106A mutant capsids treated with urea. The loss of secondary structure of capsid phosphorylated by PKC was less marked than in S106A mutant capsid incubated in the presence of PKC or WT alone. Capsid structural stability was thus increased by PKCmediated phosphorylation. These results show that, although PKC-mediated phosphorylation decreased the ratio of α-helix content in capsids, it increased structural stability.
Comparison of core assembly and virus titres between WT and mutant core in Huh7 cells
To identify the effect of phosphorylation in vivo, FLAG-tagged Cp149 and S106A mutant Cp149 genes were transfected into Huh7 cells. Although the total amount of expressed Cp149 was the
Figure 6 CD analysis
All samples were analysed by CD in 20 mM Tris/HCl, pH 7.2, with or without urea. Spectra were obtained using a 2 nm bandwidth, a scan rate of 100 nm/min and the response time of 1 s. Trace A, urea untreated Cp149 capsid; trace B, urea untreated S106A mutant Cp149 capsid; trace C, urea untreated Cp149 capsid phosphorylated by PKC. Trace a, urea treated Cp149 capsid; trace b, urea treated S106A mutant Cp149 capsid; trace c, urea treated Cp149 capsid phopshorylated by PKC. WT, WT Cp149; S106A, S106A mutant Cp149.
Figure 7 Comparison of WT and mutant core proteins in Huh7 cells
(A) To detect core capsid in cytosol, Huh7 cells were transfected with pCMV/FLAG-core(WT) and pCMV/FLAG-core(S106A). Backbone DNA (pCMV) was transfected as a control. Top panel, capsid was separated by 0.9 % native agarose gel and detected by immunoblot analysis with anti-core antibody. Bottom panel, total proteins were separated on a SDS/15 % PAGE gel and detected by immunoblot analysis with anti-FLAG antibody. (B) To detect the effects of S106A mutation on HBV proliferation, Huh7 cells were transfected with pUC/1.2x(WT) or pUC/1.2x(S106A core mutant). Intracellular and extracellular capsid levels were detected. The methods used are described in the Materials and methods section.
same, the level of the S106A mutant capsid proteins was 1.98-fold less than that of Cp149 ( Figure 7A, top panel) . To investigate the effect of PKC-mediated phosphorylation on HBV proliferation, virus titration was performed. Huh7 cells transfected with pUC/ 1.2x(WT) and pUC/1.2x(S106A) were cultured, and the levels of intracellular and extracellular HBV particles were measured. We found that the levels of intracellular S106A mutant HBV were 2.02-fold lower than that of the WT Cp149 HBV ( Figure 7B) . Similarly, the levels of extracellular S106A HBV levels were 2.31-fold lower than that of WT Cp149 HBV ( Figure 7B) . The results were confirmed by checking HBV DNA (results not shown). These results suggest that PKC-mediated phosphorylation may affects HBV proliferation.
Electron micrograph of assembled WT and Ser 106 mutant
To examine further the effect of PKC phosphorylation and mutation of the S106 residue on Cp149 on capsid formation, Figure 8 Electron micrographs of assembled core particle
Electromicrographs of Cp149 and S106A mutant Cp149 capsids. Assembled core particles were negatively stained with 2 % uracyl acetate. (A) Cp149 core was assembled in reaction buffer (20 mM Hepes, pH 7.5, and 2.75 mM CaCl 2 ). (B) Cp149 core was assembled with PKC in reaction buffer. (C) S106A core mutant was assembled in reaction buffer.
in vitro-assembled core particles were examined by TEM (transmission electron microscopy). In previous reports, the diameter of WT Cp149 was determined to be approx. 30 nm [10] . Analysis of electronmicrographs showed the approximate diameter of the WT Cp149 capsid ( Figure 8A ) and the PKC-treated core particle ( Figure 8B ) to be approx. 30 nm (average diameters, 30.29 nm and 29.91 nm respectively). The approximate diameter of the S106A mutant capsid ( Figure 8C ) was also estimated to be 30 nm (average diameter 30.1 nm). Thus the shapes of these capsids were almost identical ( Figures 8A-8C ). These results show that the PKC-treated Cp149 capsid, PKCuntreated Cp149 capsids and S106A mutant capsids are identical with respect to morphology.
DISCUSSION
HBV pg-RNA encapsidation is regulated through phosphorylation of the HBV core by PKC [16] . Phosphorylation sites {Thr 128 (by cdc2) [20] and Ser 87 (by PKA) [9] } in the N-terminal domain have been identified, but the role(s) of phosphorylation in the N-terminal domain remains unclear. Although PKC is packaged into the HBV core capsid, little is known regarding the phosphorylation of the N-terminal domain by PKC or the roles of PKC phosphorylation in the life cycle of HBV.
The full-length core can be expressed in E. coli and is more stable than the C-terminal truncated core [4] . However, when expressed and purified under identical conditions, the full-length core is recovered in much lower amounts and at lower purity levels than the truncated core (results not shown). Additionally, unlike in genome encapsidation, core assembly can occur without the C-terminal region of the core. When using the full length core, the amount that can be extracted is too low to perform many experiments. Taking into account the lower purity and overall amount recovered with the full-length core compared with Cp149, as well as the fact that these experiments were performed to investigate PKC phosphorylation as a factor of affecting capsid assembly and stability, we decided to use Cp149 in this study rather than the full-length core.
Using in vitro phosphorylation assays, we have demonstrated that the PKC-mediated phosphorylation of the N-terminal domain of Cp149 increased HBV capsid assembly and stability, as well as structural stability of the core protein. SPR was used to investigate the factors that caused the increased capsid assembly and stability, and revealed that increased capsid levels and stability were due primarily to an elevated rate of dimeric Cp149 association and a decreased rate of Cp149 dissociation as a result of PKC-mediated phosphorylation. Given the same concentration of Cp149, the degree of interaction was higher between P-WT/P-WT than between WT/WT. The first step of HBV core assembly is the formation of a dimeric form of the core protein subunit from its monomers. A trimer of dimers nucleates capsid assembly [21] . PKC-mediated phosphorylation may elevate the rate of intermediate formation and the subsequent addition of dimeric Cp, resulting in a marked effect on the rate of capsid formation.
Based on the results showing decreased dissociation, we investigated whether capsid stability was increased by PKCmediated phosphorylation. It was previously reported that HBV capsid dissociation is inhibited by the reassembly of intermediates [22] . We propose that capsid stability is enhanced by an increase in dimer affinity promoting the reassembly of intermediates and by a decrease in the rate of dissociation, helping to maintain corecore interactions within the capsid and inhibit core dissociation, thus maintaining capsid stability.
It was reported that PKC-mediated phosphorylation induces conformational change [23] and regulates protein interactions [24] . We showed that PKC-mediated phosphorylation decreased the α-helix ratio of Cp149, but inhibited the loss of secondary structure. These results suggest that PKC-mediated phosphorylation not only increases capsid levels and stability but also induces conformational changes that increased structural stability.
The PKC phosphorylation site at Ser 106 in the N-terminal domain of Cp is located in the α4b region, which is known to be important for the folding stability of Cp and is close to an important site of interaction between Cp dimers [19] . Cations such as Na + , Zn 2+ and Ca 2+ facilitate core assembly by altering protein conformations [17, 25, 26] . PKC-mediated phosphorylation may increase core affinity and stability and decrease dissociation by altering the conformation of Cp.
PKA phosphorylates the core, and increases core affinity and capsid assembly [9] . We also found that PKA phosphorylation increased capsid stability (Supplementary Figure S1 , at http://www.BiochemJ.org/bj/416/bj4160047add.htm). PKA phosphorylation decreases the α-helix ratio of core but has no effect on capsid structural stability (Supplementary Figure S2 , at http://www.BiochemJ.org/bj/416/bj4160047add.htm). PKA phosphorylation has been reported to increase core affinity by the same mechanism as PKC. PKA phosphorylation increased the reassembly of intermediates and capsid stability. Ser 87 is not located in the α4b region, a site known to be important for core folding stability, and therefore did not affect secondary structure stability.
When the PKA-phosphorylated core was phosphorylated by PKC or the PKC-phosphorylated core was phosphorylated by PKA, overall phosphorylation levels were reduced (Supplementary Figure S3A , at http://www.BiochemJ.org/bj/416/ bj4160047add.htm). Conformational changes induced by PKA and PKC caused a decrease in phosphorylation, but the decreased phosphorylation did not affect capsid stability (Supplementary Figure S3B ). Based on these results, core may not be phosphorylated by both PKA and PKC at the same time. Activation of PKC may decrease the effect of PKA phosphorylation on HBV core; and likewise, activation of PKA may also decrease the effect of PKC phosphorylation. It has been reported that HBx activates PKC by increasing calcium concentration [27] , but the mechanism by which HBV activates PKA is unknown. Further studies on the regulation of PKA by HBV will be necessary to clarify the mechanism.
We showed that the S106A mutant capsid level and virus titre were decreased in vivo compared with WT and therefore we suggest the possibility that PKC regulates HBV proliferation. We showed that both intracellular and extracellular levels of core particles ( Figure 7B ) and virus particles were decreased in Huh7 cells (results not shown). Phosphorylation was inhibited in cells by the core S106A mutation, decreasing core assembly and stability. The degree by which intracellular and extracellular virus particle levels decreased was similar in both WT and S106A types. Therefore, PKC phosphorylation may not affect secretion of HBV particles ( Figure 7) . The capsid assisted HBV reverse transcription and increased HBV replication [28] . On the basis of results from experiments performed in vitro, capsid levels may be elevated because of increased core affinity, capsid stability and decreased core dissociation due to PKC-mediated phosphorylation.
With the exception of the results concerning pgRNA encapsidation, there have been no reports regarding the role of PKC in the life cycle of HBV. It has been reported that several kinases phosphorylate the HBV core; however, it has not been estabilished whether any of these kinases, with the exception of PKC, are activated by HBV. It is reported that PKC is activated by HBx [15] and calcium signalling is activated by HBx [27] . These reports suggested that PKC is activated by HBV, therefore further studies are needed to understand better the relationship between PKC and HBV.
In this study, we found that capsid assembly and stability were increased through increased affinity by PKC-mediated phosphorylation of Cp149 at Ser106. We also demonstrated that the S106A mutation may affect HBV proliferation in vivo. It is known that HBV core assembly is followed by viral replication and that HBV replication is dependent on capsid formation. Our results will be useful in understanding the regulation of the HBV life cycle by the phosphorylation of the HBV core.
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